Start › Rak płuc › Tennessee › Memphis
Badania kliniczne dla Rak płuc w mieście Memphis, TN
18 badań dla Rak płuc szuka uczestników w ośrodkach w mieście Memphis i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekrutacjaFaza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RekrutacjaFaza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekrutacjaFaza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekrutacjaFaza 3
- Regional One Health, Memphis
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
RekrutacjaFaza 2
- Research Site, Memphis
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Baptist Cancer Center, Memphis
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekrutacjaFaza 3
- Baptist Memorial Hospital-Memphis, Memphis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RekrutacjaFaza 3
- Baptist Cancer Center, Southaven · 11 mi dalej
- West Cancer Center & Research Institute, Germantown · 14 mi dalej
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RekrutacjaFaza 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
RekrutacjaFaza 1/2
- Baptist Medical Center, Memphis
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
RekrutacjaFaza 2
- Baptist Cancer Center, Memphis
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekrutacjaFaza 1/2
- Baptist Memorial Hospital Baptist Cancer Center, Memphis
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekrutacjaFaza 2/3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi dalej
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi dalej
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
RekrutacjaZapraszamy zdrowych ochotników
- Baptist Clinical Research Institute, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekrutacjaBadanie obserwacyjneZapraszamy zdrowych ochotników
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekrutacjaBadanie obserwacyjne
- Massive Bio SYNERGY-AI site, Memphis
Badania dla Rak płuc w innych miastach
- Houston, TX78 badań
- Boston, MA62 badań
- New York City, NY60 badań
- Los Angeles, CA45 badań
- Washington, DC41 badań
- Arlington, VA41 badań
- Chicago, IL41 badań
- Nashville, TN40 badań
- Baltimore, MD40 badań
- St. Louis, MO39 badań
- Columbus, OH37 badań
- Philadelphia, PA36 badań
Inne badania w mieście Memphis
- Nowotwory (wszystkie typy)31 badań
- Niedrobnokomórkowy rak płuca23 badań
- Rak piersi22 badań
- Anemia sierpowata18 badań
- Ostra białaczka limfoblastyczna16 badań
- Ostra białaczka szpikowa15 badań
- Niewydolność serca13 badań
- Rak jelita grubego i odbytnicy11 badań
- Mięsak tkanek miękkich11 badań
- Czerniak11 badań
- Rak prostaty11 badań
- Mięsak kościopochodny10 badań
Źródło: ClinicalTrials.gov, dane pobrane 5 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.